Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara J Zarowitz

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Gastroenterology Clinics of North America|August 25, 2009
Pharmacologic consideration of commonly used gastrointestinal drugs in the elderlyBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|February 18, 2010
Trick or TREAT? More condemning evidence against ESAsBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|August 13, 2008
The generic imperativeBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|November 8, 2011
Polypharmacy: when is enough, enough?Barbara J Zarowitz
Journal of the American Geriatrics Society|August 5, 2005
The class effect is relevant to geriatricsBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|October 31, 2013
Dipeptyl peptidase - 4 inhibitors in type 2 diabetes: cardiovascular risk reduction?Barbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|April 9, 2008
The value of vitamin D(3) over vitamin D(2) in older personsBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|November 9, 2010
Opportunity to optimize management of benign prostatic hyperplasiaBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|June 15, 2007
Erythropoietic-stimulating agents (ESAs): new safety warningBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|April 3, 2012
Therapeutic experimentation in the elderlyBarbara J Zarowitz
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Gastroenterology Clinics of North America|August 25, 2009
Pharmacologic consideration of commonly used gastrointestinal drugs in the elderlyBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|February 18, 2010
Trick or TREAT? More condemning evidence against ESAsBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|August 13, 2008
The generic imperativeBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|November 8, 2011
Polypharmacy: when is enough, enough?Barbara J Zarowitz
Journal of the American Geriatrics Society|August 5, 2005
The class effect is relevant to geriatricsBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|October 31, 2013
Dipeptyl peptidase - 4 inhibitors in type 2 diabetes: cardiovascular risk reduction?Barbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|April 9, 2008
The value of vitamin D(3) over vitamin D(2) in older personsBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|November 9, 2010
Opportunity to optimize management of benign prostatic hyperplasiaBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|June 15, 2007
Erythropoietic-stimulating agents (ESAs): new safety warningBarbara J Zarowitz
Geriatric Nursing (New York, N.Y.)|April 3, 2012
Therapeutic experimentation in the elderlyBarbara J Zarowitz
Pageof 11